A Global Evolution in Medical Technology
Since 2007, under the collective umbrella of the INVAMED group of companies, we have continually forged advanced solutions to address the ever-evolving needs of modern healthcare. Our earliest developments—focused on specialized catheter systems—laid the groundwork for groundbreaking endovascular innovations. Over time, this ethos of pioneering engineering has expanded to encompass a comprehensive array of minimally invasive and high-precision therapies, securing INVAMED’s position as a trusted partner for healthcare professionals worldwide.
A Commitment to Excellence Across Our Surgical Specialties
Driven by relentless research, strategic partnerships, and select acquisitions (including Cytronics for orthopedic and spinal technologies), INVAMED now serves a wide range of distinct surgical specialties:
Venous
Arterial, Peripheral
Interventional Cardiology, Cardiac
Aortic
Orthopedics & Trauma
Oncological Surgery
Gastrointestinal, Colorectal, Proctology
Neurosurgery
Neurovascular
Urology
General Surgery
Plastic, Reconstructive & Laser Dermatology
Ear, Nose & Throat (ENT)
Thoracic
Algology, Pain Management
Ophthalmology
Endocrine Surgery
Digital Health
Within these fields, our portfolio spans a diverse spectrum of laser therapies, adhesive-based vein treatments, drug-coated balloons, stent platforms, radiofrequency (RF) ablation devices, and beyond. Each product integrates the latest engineering insights and clinical input, providing specialists with the precision and reliability essential for improved patient outcomes.
Key Highlights of Innovation
Laser-Assisted Solutions: From varicose veins and hemorrhoids to ophthalmic procedures, our laser platforms deliver targeted energy with minimal collateral impact—shortening recovery times while enhancing procedural control.
Ablative & Adhesive Therapies: Innovative “Turkish Glue” for varicose veins and advanced atherectomy devices illustrate our dedication to reducing procedural invasiveness while maximizing therapeutic efficacy.
Comprehensive Stent & Catheter Ranges: Coronary, peripheral, and aortic stent-grafts; drug-coated balloons; and specialized support catheters—integrated with intuitive imaging—to streamline complex vascular procedures.
Orthopedic & Dental Expansions: Through the acquisition of Cytronics, our offerings include spinal implants, orthopedic instrumentation, and state-of-the-art dental systems, reinforcing our multi-specialty capabilities.
Looking Beyond 2024: Advancing with AI and Supercomputing
Poised at the forefront of digital transformation, INVAMED invests heavily in artificial intelligence (AI), supercomputing, and predictive analytics to revolutionize surgical planning and real-time clinical decision support. Through these next-generation platforms, we strive to:
Refine Device Performance: Utilizing big data to optimize everything from stent designs to ablation energy parameters.
Enhance Personalization: Leveraging AI-driven insights for patient-specific treatment pathways, reducing risk and improving recovery.
Accelerate Research: Harnessing supercomputing power to rapidly prototype, test, and refine devices—cutting development times while adhering to rigorous scientific and regulatory standards.
Patient-Focused, Clinically Validated
Every INVAMED product is grounded in scientific rigor, multidisciplinary expertise, and comprehensive clinical validation. This ensures that our clients—whether hospitals, surgeons, or researchers—benefit from reliable, state-of-the-art solutions tailored to meet the most challenging procedural demands.